Loss of <i>BAP1</i> expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development
Carlos R. Figueiredo(University of Liverpool), Sarah E. Coupland(University of Liverpool)
Cited by 157
Related Papers
A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo
|Scientific Reports|2015|23
TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity
|Genes and Immunity|2024|16
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities
|The Journal of Pathology|2023|10